Resources from the same session
825O - Ivosidenib in Chinese patients (pts) with relapsed/refractory acute myeloid leukemia (R/R AML) with an IDH1 mutation: Results from a bridging registrational study
Presenter: Mingyuan Sun
Session: Proffered Paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
826O - Copanlisib plus rituximab vs placebo plus rituximab in patients (pts) with relapsed marginal zone lymphoma (MZL) treated in the phase III CHRONOS-3 trial
Presenter: Muhit Özcan
Session: Proffered Paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
833O - A phase Ib study result of HMPL-689, a PI3Kδ inhibitor, in Chinese patients with relapsed/refractory lymphoma
Presenter: Junning Cao
Session: Proffered Paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant 825O
Presenter: Markus Manz
Session: Proffered Paper session - Haematological malignancies
Resources:
Slides
Webcast
Invited Discussant 826O and 827O
Presenter: Lena Specht
Session: Proffered Paper session - Haematological malignancies
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lena Specht
Session: Proffered Paper session - Haematological malignancies
Resources:
Slides
Webcast